Security
GUIDED THERAPEUTICS INC Common Stock · GTHPD
GTHPDOTCCommon stockHistorical · closed Apr 25, 2019CIK 924515Updated Nov 18, 2026
GTHPD price & chart
This listing closed Apr 25, 2019. Live provider charts are shown only for current listings.
Current security: GTHP
In the news
No coverage from other publishers is available.
Recent filings
10-Q filing
10-Q filing
10-K filing
4 filing
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Other Events
Items 1.01, 3.02, 8.01, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 903,000Source | 1,249,000Source | 1,195,000Source | 940,000Source | 1,251,000Source | 1,604,000Source | 967,000Source | 1,494,000Source | 1,324,000Source | 1,378,000Source | 1,669,000Source | 3,366,000Source |
| Property, Plant and Equipment, NetUSD | 18,000Source | 25,000Source | 11,000Source | 18,000Source | 28,000Source | 13,000Source | 21,000Source | 30,000Source | 16,000Source | 23,000Source | 32,000Source | 42,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | — | — | — | — | — | — | — | — | — | — | 2,313,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 6,000Source | 2,000Source | 4,000Source | 8,000Source | 2,000Source | 4,000Source | 2,000Source | 7,000Source | 4,000Source | 3,000Source | 7,000Source | 6,000Source |
| Inventory, NetUSD | 583,000Source | 636,000Source | 500,000Source | 595,000Source | 632,000Source | 469,000Source | 633,000Source | 632,000Source | 448,000Source | 633,000Source | 632,000Source | 548,000Source |
| Assets, CurrentUSD | 799,000Source | 1,043,000Source | 527,000Source | 811,000Source | 1,021,000Source | 911,000Source | 811,000Source | 1,240,000Source | 605,000Source | 1,197,000Source | 1,393,000Source | 3,004,000Source |
| Operating Lease, Right-of-Use AssetUSD | 69,000Source | 164,000Source | 640,000Source | 94,000Source | 185,000Source | 663,000Source | 118,000Source | 207,000Source | 686,000Source | 141,000Source | 227,000Source | 303,000Source |
| Other Assets, NoncurrentUSD | 17,000Source | 17,000Source | 17,000Source | 17,000Source | 17,000Source | 17,000Source | 17,000Source | 17,000Source | 17,000Source | 17,000Source | 17,000Source | 17,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 6,549,000Source | 6,167,000Source | 6,958,000Source | 6,412,000Source | 5,918,000Source | 6,780,000Source | 5,995,000Source | 5,506,000Source | 7,330,000Source | 6,267,000Source | 5,475,000Source | 6,249,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 3,469,000Source | 3,446,000Source | 3,481,000Source | 3,465,000Source | 3,442,000Source | 3,481,000Source | 3,464,000Source | 3,441,000Source | 3,471,000Source | 3,452,000Source | 3,441,000Source | 3,437,000Source |
| Additional Paid in CapitalUSD | 145,212,000Source | 141,757,000Source | 148,843,000Source | 144,041,000Source | 141,320,000Source | 148,826,000Source | 143,616,000Source | 141,218,000Source | 146,092,000Source | 142,501,000Source | 140,983,000Source | 138,090,000Source |
| Retained Earnings (Accumulated Deficit)USD | -155,813,000Source | -153,009,000Source | -158,672,000Source | -155,028,000Source | -152,317,000Source | -158,068,000Source | -154,172,000Source | -151,559,000Source | -157,055,000Source | -153,709,000Source | -151,118,000Source | -147,359,000Source |
| Stockholders' Equity Attributable to ParentUSD | -5,646,000Source | -4,918,000Source | -5,763,000Source | -5,472,000Source | -4,667,000Source | -5,176,000Source | -5,028,000Source | -4,012Source | -6,006,000Source | -4,889,000Source | -3,806,000Source | -2,883,000Source |
| Liabilities and EquityUSD | 903,000Source | 1,249,000Source | 1,195,000Source | 940,000Source | 1,251,000Source | 1,604,000Source | 967,000Source | 1,494,000Source | 1,324,000Source | 1,378,000Source | 1,669,000Source | 3,366,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 6,470,000Source | 6,025,000Source | 6,169,000Source | 6,377,000Source | 5,732,000Source | 5,962,000Source | 5,899,000Source | 5,342,000Source | 6,636,000Source | 6,155,000Source | 4,809,000Source | 4,869,000Source |
| Operating Lease, Liability, CurrentUSD | 76,000Source | 102,000Source | 81,000Source | 104,000Source | 99,000Source | 58,000Source | 110,000Source | 95,000Source | 45,000Source | 106,000Source | 91,000Source | 79,000Source |
| Accounts Payable, CurrentUSD | 2,382,000Source | 2,100,000Source | 2,347,000Source | 2,255,000Source | 2,143,000Source | 2,277,000Source | 2,152,000Source | 1,924,000Source | 2,416,000Source | 2,094,000Source | 1,991,000Source | 2,186,000Source |
| Operating Lease, Liability, NoncurrentUSD | 0Source | 76,000Source | 602,000Source | 0Source | 104,000Source | 627,000Source | 20,000Source | 130,000Source | 651,000Source | 49,000Source | 155,000Source | 246,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 952,000Source | 923,000Source | 1,242,000Source | 1,117,000Source | 840,000Source | 1,129,000Source | 1,062,000Source | 780,000Source | 1,718,000Source | 1,011,000Source | 970,000Source | 1,247,000Source |
| Deferred Revenue, CurrentUSD | 689,000Source | 748,000Source | 189,000Source | 679,000Source | 748,000Source | 189,000Source | 670,000Source | 748,000Source | 189,000Source | 849,000Source | 424,000Source | 509,000Source |
| Dividends Payable, CurrentUSD | 171,000Source | 188,000Source | 120,000Source | 201,000Source | 210,000Source | 128,000Source | 250,000Source | 178,000Source | 195,000Source | 227,000Source | 228,000Source | 231,000Source |
| Long-term Debt, Current MaturitiesUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 17,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Long-term Debt | — | — | —Source | — | — | —Source | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | -500,000Source | -427,000Source | — | -2,417,000Source | -3,489,000Source | -4,341,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 68,000Source | 19,000Source | 377,000Source | 120,000Source | 1,806,000Source | 176,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 0Source | -1,000Source | 7,000Source | -6,000Source | 3,000Source | -16,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 21,000Source | 0Source | -185,000Source | 1,000Source | 84,000Source | 58,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -617,000Source | -331,000Source | -1,068,000Source | -1,119,000Source | -1,746,000Source | -1,478,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | — | — | -2,000Source | — | — | -31,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | — | 2,000Source | — | 0Source | 31,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 923,000Source | 58,000Source | 745,000Source | 916,000Source | 24,000Source | 3,180,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | — | -273,000Source | — | -203,000Source | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 87,000Source | 194,000Source | 12,000Source | 185,000Source | 369,000Source | 115,000Source | 63,000Source | 388,000Source | 591,000Source | 2,314,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 23,000Source | 20,000Source | 61,000Source | 51,000Source | 107,000Source | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | — | — | — | — | 377,000Source | — | 235,980Source | — |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | 48,000Source | 67,000Source | 244,000Source | 93,000Source | 130,000Source | 143,000Source |
| DepreciationUSD | — | — | — | — | — | — | 2,000Source | 2,000Source | 10,000Source | 9,000Source | 9,000Source | 4,000Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | — | -37,000Source | -1,000Source | 9,000Source | 30,000Source | 13,000Source | 52,000Source | 65,000Source | — | — | — |
| Dividends Payable, CurrentUSD | — | — | 171,000Source | 188,000Source | 120,000Source | 201,000Source | 128,000Source | 250,000Source | 195,000Source | 227,000Source | 228,000Source | 231,000Source |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | — | — | — | — | — | — | — | — | — | — | 177,685Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | -106,000Source | 0Source | 0Source | 0Source | 0Source | -32,000Source | -533,000Source | — | 0Source | -655,000Source |
| General and Administrative ExpenseUSD | — | — | 362,000Source | 374,000Source | 423,000Source | 658,000Source | 451,000Source | 267,000Source | 2,305,000Source | 1,297,000Source | 2,997,000Source | 3,007,000Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -742,000Source | -654,000Source | -605,000Source | -811,000Source | -500,000Source | -427,000Source | -3,196,000Source | -2,417,000Source | -3,489,000Source | -4,341,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -785,000Source | -692,000Source | -604,000Source | -856,000Source | -1,013,000Source | -463,000Source | -3,346,000Source | -2,591,000Source | -3,759,000Source | -4,972,000Source |
| Nonoperating Income (Expense)USD | — | — | — | -93,000Source | — | -48,000Source | — | -13,000Source | — | -309,000Source | -32,000Source | — |
| Operating ExpensesUSD | — | — | 520,000Source | 561,000Source | 478,000Source | 842,000Source | 302,000Source | 414,000Source | 2,943,000Source | 2,110,000Source | 3,493,000Source | 3,265,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | 42,000Source | 27,000Source | 114,312Source | 109,404Source | — | — |
| Other Nonoperating Income (Expense)USD | — | — | -257,000Source | -93,000Source | -127,000Source | -48,000Source | -198,000Source | -13,000Source | -824,000Source | 18,000Source | 39,000Source | -1,008,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 0Source | 205,000Source | 567,000Source | — | 0Source | 1,392,000Source |
| Stock or Unit Option Plan ExpenseUSD | — | — | — | — | — | — | 60,000Source | 19,000Source | 106,574Source | 80,155Source | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 60,000Source | 0Source | 0Source | 117,000Source | 0Source | 0Source | 767,000Source | 7,000Source | 98,000Source | 13,000Source |
| Cost of RevenueUSD | — | — | 25,000Source | 0Source | 0Source | 38,000Source | 0Source | 0Source | 196,000Source | 5,000Source | 62,000Source | 81,000Source |
| Operating Income (Loss)USD | — | — | -485,000Source | -561,000Source | -478,000Source | -763,000Source | -302,000Source | -414,000Source | -2,372,000Source | -2,108,000Source | -3,457,000Source | -3,333,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -257,000Source | -93,000Source | -127,000Source | -48,000Source | -198,000Source | -13,000Source | -824,000Source | 18,000Source | 39,000Source | -1,008,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -742,000Source | -654,000Source | -605,000Source | -811,000Source | -500,000Source | -427,000Source | -3,196,000Source | -2,417,000Source | — | — |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -742,000Source | -654,000Source | -605,000Source | -811,000Source | -500,000Source | -427,000Source | -3,196,000Source | -2,417,000Source | -3,489,000Source | -4,341,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.01Source | -0.01Source | -0.01Source | -0.01Source | -0.01Source | -0.01Source | -0.04Source | -0.05Source | -0.07Source | -0.15Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.01Source | -0.01Source | -0.01Source | -0.01Source | -0.01Source | -0.01Source | -0.04Source | -0.05Source | -0.07Source | -0.15Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 81,689,000Source | 57,039,000Source | 96,536,000Source | 78,838,000Source | 88,836,000Source | 68,291,000Source | 78,414,000Source | — | — | 32,505,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 81,689,000Source | 57,039,000Source | 96,536,000Source | 78,838,000Source | 88,836,000Source | 68,291,000Source | 78,414,000Source | 57,339,000Source | 51,131,000Source | 32,505,000Source |
| Additional Financial Items | ||||||||||||
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| General and Administrative ExpenseUSD | — | — | 362,000Source | 374,000Source | 423,000Source | 658,000Source | 451,000Source | 267,000Source | 2,305,000Source | 1,297,000Source | 2,997,000Source | 3,007,000Source |
| Gross ProfitUSD | — | — | 35,000Source | 0Source | 0Source | 79,000Source | 0Source | 0Source | 571,000Source | 2,000Source | 36,000Source | -68,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | — | — | — | — | — | -0.01Source | — | -0.05Source | -0.07Source | -0.15Source |
| Interest ExpenseUSD | — | — | 129,000Source | 108,000Source | 136,000Source | 157,000Source | 151,000Source | 147,000Source | 617,000Source | 381,000Source | 278,000Source | 582,000Source |
| Interest Income, OperatingUSD | — | — | — | 0Source | — | 0Source | — | 0Source | — | 3,000Source | 6,000Source | — |
| Interest Income, OtherUSD | — | — | 0Source | 0Source | — | — | — | — | 0Source | — | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -785,000Source | -692,000Source | -604,000Source | -856,000Source | -1,013,000Source | -463,000Source | -3,346,000Source | -2,591,000Source | -3,759,000Source | -4,972,000Source |
| Nonoperating Income (Expense)USD | — | — | — | -93,000Source | — | -48,000Source | — | -13,000Source | — | -309,000Source | -32,000Source | — |
| Operating ExpensesUSD | — | — | 520,000Source | 561,000Source | 478,000Source | 842,000Source | 302,000Source | 414,000Source | 2,943,000Source | 2,110,000Source | 3,493,000Source | 3,265,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | 42,000Source | 27,000Source | 114,312Source | 109,404Source | — | — |
| Other IncomeUSD | — | — | 0Source | 0Source | 0Source | 64,000Source | 15,000Source | 98,000Source | 165,000Source | — | — | 16,000Source |
| Preferred Stock Dividends, Income Statement ImpactUSD | — | — | — | — | — | — | — | 500,000Source | — | 2,500,000Source | — | — |
| Research and Development ExpenseUSD | — | — | 136,000Source | 111,000Source | 34,000Source | 133,000Source | 45,000Source | 74,000Source | 469,000Source | 526,000Source | 228,000Source | 77,000Source |
| Selling and Marketing ExpenseUSD | — | — | 22,000Source | 76,000Source | 23,000Source | 51,000Source | 23,000Source | 73,000Source | 169,000Source | 287,000Source | 268,000Source | 181,000Source |
| Preferred Stock Dividends and Other Adjustments | — | — | —Source | —Source | —Source | —Source | — | — | — | — | — | — |
Filing attachments
gthp_ex107.htm · 10-Q · 2026-08-13
EXHIBIT 10.7 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of August 5, 2026, by and between GUIDED THERAPEUTICS, INC., a Delaware corporation, with headquarters located at 5835 Peachtree Corners East, Suite B, Peachtree Corners, GA 30092 (the “Company”) and GS CAPITAL PARTNERS, LLC, with its address at 1325 Airmotive Way, Suite 202, Reno, NV 89502 (the “Buyer”). WHEREAS: A. The Company and the Buyer are executing and delivering this Agreement i…
Read attachment ↗